Go Pro
NASDAQ:AIFF

Firefly Neuroscience Q4 2024 Earnings Report

Firefly Neuroscience logo
$2.01 +0.82 (+68.91%)
Closing price 09/25/2026 04:00 PM Eastern
Extended Trading
$1.82 -0.19 (-9.20%)
As of 09/25/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Firefly Neuroscience EPS Results

Actual EPS
-$0.45
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Firefly Neuroscience Revenue Results

Actual Revenue
$0.05 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Firefly Neuroscience Announcement Details

Quarter
Q4 2024
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Firefly Neuroscience Earnings Headlines

Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.tc pixel
Firefly Hikes on Partnering with NeuroSigma
See More Firefly Neuroscience Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Firefly Neuroscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Firefly Neuroscience and other key companies, straight to your email.

About Firefly Neuroscience

Firefly Neuroscience (NASDAQ:AIFF) is a medical technology company focused on applying artificial intelligence to brain health and neurological care. The company develops software designed to analyze electroencephalography (EEG) data and identify objective patterns associated with cognitive and mental health conditions.

Its principal offering is the Brain Network Analytics (BNA) platform, which uses machine-learning algorithms to evaluate brain activity and generate biomarkers intended to support the assessment, monitoring and management of conditions such as cognitive impairment and depression. The platform is designed to help clinicians complement conventional evaluations with data-driven insights into brain function.

Firefly Neuroscience serves healthcare providers, researchers and other organizations involved in neuroscience and mental health. The company’s technology is focused primarily on clinical and research applications, although specific geographic markets and commercial partnerships may evolve as adoption expands. Firefly Neuroscience is led by Chief Executive Officer Jon Olsen.

View Firefly Neuroscience Profile